3941 - 3950 of 9118 Results
Title
Year
-
OPENTitle: Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over TimeJournal Name: AssessmentPublisher: SAGE PublicationsVol: 28Issue #: 6Start Page: 1708End Page: 1722Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1073191120915273Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1073191120915273Citation Count: 10
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 39
-
OPENTitle: Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNAJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 117Issue #: 3Start Page: 1457End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1905057117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1457.full.pdfCitation Count: 121
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 25
-
OPENTitle: Identification and Management of Persistent Stimulation-Induced Dyskinesia Associated with STN DBS: The See-Saw DilemmaJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 13Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.780Best OA location URL: https://storage.googleapis.com/jnl-up-j-tohm-files/journals/1/articles/780/64eca1ba44139.pdfCitation Count: 8
-
OPENTitle: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104623End Page: 104623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996119302980?via%3DihubCitation Count: 107
-
OPENTitle: Intermediate Deformable Image Registration Via Windowed Cross-CorrelationJournal Name: 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI)Publisher: IEEEVol:Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/isbi53787.2023.10230715Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10485808/pdf/nihms-1872292.pdfCitation Count: 2
-
OPENTitle: Beyond ATP, new roles of mitochondriaJournal Name: The BiochemistPublisher: Portland Press Ltd.Vol: 44Issue #: 4Start Page: 2End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bio_2022_119Best OA location URL: https://portlandpress.com/biochemist/article-pdf/44/4/2/937405/bio_2022_119.pdfCitation Count: 88
-
OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 85